- Home
- QMCO vs AGEN Comparison
QMCO vs AGEN Comparison
Compare QMCO & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- AGEN
- Stock Information
- Founded
- QMCO 1980
- AGEN 1994
- Country
- QMCO United States
- AGEN United States
- Employees
- QMCO N/A
- AGEN N/A
- Industry
- QMCO Electronic Components
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QMCO Technology
- AGEN Health Care
- Exchange
- QMCO Nasdaq
- AGEN Nasdaq
- Market Cap
- QMCO 86.9M
- AGEN 87.7M
- IPO Year
- QMCO N/A
- AGEN 2000
- Fundamental
- Price
- QMCO $8.43
- AGEN $4.80
- Analyst Decision
- QMCO Hold
- AGEN Buy
- Analyst Count
- QMCO 2
- AGEN 4
- Target Price
- QMCO $19.00
- AGEN $13.00
- AVG Volume (30 Days)
- QMCO 2.6M
- AGEN 1.6M
- Earning Date
- QMCO 08-12-2025
- AGEN 08-07-2025
- Dividend Yield
- QMCO N/A
- AGEN N/A
- EPS Growth
- QMCO N/A
- AGEN N/A
- EPS
- QMCO N/A
- AGEN N/A
- Revenue
- QMCO $285,865,000.00
- AGEN $99,524,000.00
- Revenue This Year
- QMCO N/A
- AGEN $12.69
- Revenue Next Year
- QMCO $2.46
- AGEN N/A
- P/E Ratio
- QMCO N/A
- AGEN N/A
- Revenue Growth
- QMCO N/A
- AGEN N/A
- 52 Week Low
- QMCO $2.22
- AGEN $1.38
- 52 Week High
- QMCO $90.64
- AGEN $18.74
- Technical
- Relative Strength Index (RSI)
- QMCO 35.79
- AGEN 54.50
- Support Level
- QMCO $9.81
- AGEN $4.38
- Resistance Level
- QMCO $10.69
- AGEN $5.20
- Average True Range (ATR)
- QMCO 0.85
- AGEN 0.57
- MACD
- QMCO -0.25
- AGEN -0.10
- Stochastic Oscillator
- QMCO 5.09
- AGEN 43.60
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).